Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 11 studies | 44% ± 10% | |
glutamatergic neuron | 11 studies | 60% ± 28% | |
astrocyte | 11 studies | 42% ± 18% | |
GABAergic neuron | 9 studies | 54% ± 25% | |
smooth muscle cell | 7 studies | 31% ± 9% | |
interneuron | 6 studies | 51% ± 29% | |
neuron | 5 studies | 45% ± 25% | |
pericyte | 5 studies | 36% ± 17% | |
endothelial cell | 5 studies | 45% ± 10% | |
GABAergic interneuron | 3 studies | 46% ± 14% | |
microglial cell | 3 studies | 47% ± 24% | |
retinal bipolar neuron | 3 studies | 43% ± 18% | |
OFF-bipolar cell | 3 studies | 51% ± 24% | |
rod bipolar cell | 3 studies | 58% ± 31% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 13 studies | 43% ± 24% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 2541.34 | 2605 / 2642 | 96% | 12.92 | 676 / 705 |
uterus | 82% | 423.28 | 140 / 170 | 6% | 0.29 | 28 / 459 |
esophagus | 61% | 605.66 | 887 / 1445 | 9% | 0.27 | 17 / 183 |
intestine | 62% | 285.88 | 598 / 966 | 5% | 0.22 | 25 / 527 |
adrenal gland | 12% | 35.27 | 30 / 258 | 51% | 5.73 | 118 / 230 |
bladder | 57% | 147.90 | 12 / 21 | 3% | 0.12 | 14 / 504 |
stomach | 30% | 168.94 | 109 / 359 | 4% | 0.47 | 11 / 286 |
kidney | 8% | 13.70 | 7 / 89 | 2% | 0.05 | 22 / 901 |
pancreas | 0% | 0.55 | 1 / 328 | 8% | 0.24 | 14 / 178 |
prostate | 6% | 14.20 | 14 / 245 | 2% | 0.09 | 10 / 502 |
lung | 1% | 1.89 | 7 / 578 | 5% | 0.13 | 57 / 1155 |
skin | 4% | 7.89 | 69 / 1809 | 2% | 0.15 | 11 / 472 |
adipose | 5% | 8.25 | 62 / 1204 | 0% | 0 | 0 / 0 |
muscle | 5% | 10.47 | 41 / 803 | 0% | 0 | 0 / 0 |
heart | 5% | 7.79 | 42 / 861 | 0% | 0 | 0 / 0 |
ovary | 2% | 6.82 | 4 / 180 | 2% | 0.11 | 10 / 430 |
breast | 4% | 5.61 | 17 / 459 | 1% | 0.02 | 7 / 1118 |
thymus | 3% | 4.79 | 20 / 653 | 0% | 0 | 0 / 605 |
blood vessel | 2% | 4.34 | 30 / 1335 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 2% | 0.04 | 9 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006654 | Biological process | phosphatidic acid biosynthetic process |
GO_0046339 | Biological process | diacylglycerol metabolic process |
GO_0007205 | Biological process | protein kinase C-activating G protein-coupled receptor signaling pathway |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0046486 | Biological process | glycerolipid metabolic process |
GO_0030168 | Biological process | platelet activation |
GO_0046834 | Biological process | lipid phosphorylation |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0045211 | Cellular component | postsynaptic membrane |
GO_0005509 | Molecular function | calcium ion binding |
GO_0004143 | Molecular function | ATP-dependent diacylglycerol kinase activity |
GO_0008289 | Molecular function | lipid binding |
GO_0005524 | Molecular function | ATP binding |
Gene name | DGKB |
Protein name | Diacylglycerol kinase beta Diacylglycerol kinase (DAG kinase) (EC 2.7.1.107) Diacylglycerol kinase beta (DAG kinase beta) (EC 2.7.1.107) (90 kDa diacylglycerol kinase) (Diglyceride kinase beta) (DGK-beta) |
Synonyms | KIAA0718 DAGK2 |
Description | FUNCTION: Diacylglycerol kinase that converts diacylglycerol/DAG into phosphatidic acid/phosphatidate/PA and regulates the respective levels of these two bioactive lipids . Thereby, acts as a central switch between the signaling pathways activated by these second messengers with different cellular targets and opposite effects in numerous biological processes (Probable). Has a higher activity with long-chain diacylglycerols like 1,2-di-(9Z-octadecenoyl)-sn-glycerol compared to 1,2-didecanoyl-sn-glycerol (By similarity). Specifically expressed in brain, it regulates neuron-specific morphological changes including neurite branching and neurite spine formation (By similarity). .; FUNCTION: [Isoform 2]: Does not associate with membranes but has a diacylglycerol kinase activity. . |
Accessions | B5MCD5 ENST00000437998.1 Q9Y6T7 ENST00000399322.7 [Q9Y6T7-1] ENST00000407950.5 B7ZL83 B5MBY2 ENST00000403951.6 [Q9Y6T7-1] C9JA18 ENST00000402815.6 ENST00000406247.7 [Q9Y6T7-2] |